A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
8
Participants
Timeline
Start Date
October 31, 2016
Primary Completion Date
September 30, 2017
Study Completion Date
September 30, 2017
Conditions
Carcinoma, Non-Small-Cell LungAdenocarcinoma
Interventions
DRUG
VAL401
Risperidone formulated into a liquid lipid filled capsule
All Listed Sponsors
lead
ValiSeek Limited
INDUSTRY
NCT02875340 - A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter